Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rocket Pharmaceuticals (RCKT) Goodwill & Intangibles: 2018-2025

Historic Goodwill & Intangibles for Rocket Pharmaceuticals (RCKT) over the last 8 years, with Sep 2025 value amounting to $64.3 million.

  • Rocket Pharmaceuticals' Goodwill & Intangibles changed negligibly% to $64.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $64.3 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $64.3 million for FY2024, which is negligibly% changed negligibly from last year.
  • Latest data reveals that Rocket Pharmaceuticals reported Goodwill & Intangibles of $64.3 million as of Q3 2025, which was down 0.00% from $64.3 million recorded in Q2 2025.
  • In the past 5 years, Rocket Pharmaceuticals' Goodwill & Intangibles ranged from a high of $64.9 million in Q4 2022 and a low of $30.8 million during Q1 2021.
  • Its 3-year average for Goodwill & Intangibles is $64.5 million, with a median of $64.3 million in 2025.
  • Per our database at Business Quant, Rocket Pharmaceuticals' Goodwill & Intangibles spiked by 110.69% in 2022 and then fell by 0.88% in 2023.
  • Over the past 5 years, Rocket Pharmaceuticals' Goodwill & Intangibles (Quarterly) stood at $30.8 million in 2021, then skyrocketed by 110.69% to $64.9 million in 2022, then declined by 0.88% to $64.3 million in 2023, then remained steady at $64.3 million in 2024, then remained steady at $64.3 million in 2025.
  • Its last three reported values are $64.3 million in Q3 2025, $64.3 million for Q2 2025, and $64.3 million during Q1 2025.